Atrophie : Questions médicales fréquentes

Nom anglais: Atrophy

Descriptor UI: D001284

Tree Number: C23.300.070

Termes MeSH sélectionnés :

Patient Preference

Questions fréquentes et termes MeSH associés

Diagnostic 1

#1

Quels sont les principaux critères de diagnostic pour les Atrophie ?

Les critères de diagnostic seront détaillés lors de la prochaine génération.
Atrophy Diagnosis

Traitement 1

#1

Quelles sont les approches thérapeutiques principales pour Atrophie ?

Les approches thérapeutiques seront détaillées lors de la prochaine génération.
Atrophy Therapeutics

Prévention 1

#1

Comment prévenir les complications liées aux Atrophie ?

Les méthodes de prévention seront détaillées lors de la prochaine génération.
Atrophy Prevention and Control
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Atrophie : Questions médicales les plus fréquentes", "headline": "Atrophie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Atrophie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-26", "dateModified": "2024-11-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Atrophie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "États anatomopathologiques", "url": "https://recherchemedicale.com/mesh/D020763", "about": { "@type": "MedicalCondition", "name": "États anatomopathologiques", "code": { "@type": "MedicalCode", "code": "D020763", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.300" } } }, "about": { "@type": "MedicalCondition", "name": "Atrophie", "alternateName": "Atrophy", "code": { "@type": "MedicalCode", "code": "D001284", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Iva Stankovic", "url": "https://recherchemedicale.com/author/Iva%20Stankovic", "affiliation": { "@type": "Organization", "name": "Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia." } }, { "@type": "Person", "name": "Gregor K Wenning", "url": "https://recherchemedicale.com/author/Gregor%20K%20Wenning", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria." } }, { "@type": "Person", "name": "Klaus Seppi", "url": "https://recherchemedicale.com/author/Klaus%20Seppi", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria." } }, { "@type": "Person", "name": "Jonathan Graff-Radford", "url": "https://recherchemedicale.com/author/Jonathan%20Graff-Radford", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Mayo Clinic, Rochester, MN, USA." } }, { "@type": "Person", "name": "Frederik Barkhof", "url": "https://recherchemedicale.com/author/Frederik%20Barkhof", "affiliation": { "@type": "Organization", "name": "From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Patient preference predictor and the objection from higher-order preferences.", "datePublished": "2022-07-01", "url": "https://recherchemedicale.com/article/35777961", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/jme-2022-108427" } }, { "@type": "ScholarlyArticle", "name": "Cultural Differences in Patients' Preferences for Paternalism: Comparing Mexican and American Patients' Preferences for and Experiences with Physician Paternalism and Patient Autonomy.", "datePublished": "2022-08-26", "url": "https://recherchemedicale.com/article/36078378", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph191710663" } }, { "@type": "ScholarlyArticle", "name": "A stated preference survey to explore patient preferences for novel preventive migraine treatments.", "datePublished": "2022-09-01", "url": "https://recherchemedicale.com/article/36047857", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/head.14386" } }, { "@type": "ScholarlyArticle", "name": "Patient-Preference Diagnostics: Adapting Stated-Preference Methods to Inform Effective Shared Decision Making.", "datePublished": "2022-07-29", "url": "https://recherchemedicale.com/article/35904149", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/0272989X221115058" } }, { "@type": "ScholarlyArticle", "name": "Patient Preferences for Lung Cancer Interception Therapy.", "datePublished": "2023-11-01", "url": "https://recherchemedicale.com/article/37948077", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.42681" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://recherchemedicale.com/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "États anatomopathologiques", "item": "https://recherchemedicale.com/mesh/D020763" }, { "@type": "ListItem", "position": 4, "name": "Atrophie", "item": "https://recherchemedicale.com/mesh/D001284" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Atrophie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Atrophie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Atrophie", "description": "Quels sont les principaux critères de diagnostic pour les Atrophie ?", "url": "https://recherchemedicale.com/mesh/D001284?mesh_terms=Patient+Preference#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Traitement", "headline": "Traitement sur Atrophie", "description": "Quelles sont les approches thérapeutiques principales pour Atrophie ?", "url": "https://recherchemedicale.com/mesh/D001284?mesh_terms=Patient+Preference#section-traitement" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Atrophie", "description": "Comment prévenir les complications liées aux Atrophie ?", "url": "https://recherchemedicale.com/mesh/D001284?mesh_terms=Patient+Preference#section-prévention" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels sont les principaux critères de diagnostic pour les Atrophie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les critères de diagnostic seront détaillés lors de la prochaine génération." } }, { "@type": "Question", "name": "Quelles sont les approches thérapeutiques principales pour Atrophie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les approches thérapeutiques seront détaillées lors de la prochaine génération." } }, { "@type": "Question", "name": "Comment prévenir les complications liées aux Atrophie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les méthodes de prévention seront détaillées lors de la prochaine génération." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale

Validation scientifique effectuée le 22/11/2024

Contenu vérifié selon les dernières recommandations médicales

En savoir plus sur Dr Menir

Auteurs principaux

Iva Stankovic

3 publications dans cette catégorie

Affiliations :
  • Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Publications dans "Atrophie" :

Gregor K Wenning

3 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie" :

Klaus Seppi

3 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie" :

Jonathan Graff-Radford

3 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Publications dans "Atrophie" :

Frederik Barkhof

2 publications dans cette catégorie

Affiliations :
  • From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden.
Publications dans "Atrophie" :

Gil D Rabinovici

2 publications dans cette catégorie

Affiliations :
  • From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden.
Publications dans "Atrophie" :

Rik Ossenkoppele

2 publications dans cette catégorie

Affiliations :
  • From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden.
Publications dans "Atrophie" :

Maria Teresa Pellecchia

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Baronissi, SA, Italy.
Publications dans "Atrophie" :

Werner Poewe

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. werner.poewe@i-med.ac.at.
Publications dans "Atrophie" :

Wassilios G Meissner

2 publications dans cette catégorie

Affiliations :
  • CHU Bordeaux, Service de Neurologie - Maladies Neurodégénératives, CRMR AMS, IMNc, Bordeaux, France.
  • CNRS, IMN, UMR 5293, University of Bordeaux, Bordeaux, France.
  • New Zealand Brain Research Institute, Department of Medicine, University of Otago, Christchurch, New Zealand.
Publications dans "Atrophie" :

Horacio Kaufmann

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.
Publications dans "Atrophie" :

Megan A Waldrop

2 publications dans cette catégorie

Affiliations :
  • Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH; Departments of Pediatrics and Neurology, Ohio State University, Columbus, OH.
Publications dans "Atrophie" :

Jerry R Mendell

2 publications dans cette catégorie

Affiliations :
  • Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH; Departments of Pediatrics and Neurology, Ohio State University, Columbus, OH.
Publications dans "Atrophie" :

Florian Krismer

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie" :

Lorenzo Bianco

2 publications dans cette catégorie

Affiliations :
  • Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Publications dans "Atrophie" :

Alessio Antropoli

2 publications dans cette catégorie

Publications dans "Atrophie" :

Alessandro Arrigo

2 publications dans cette catégorie

Publications dans "Atrophie" :

Alessandro Berni

2 publications dans cette catégorie

Publications dans "Atrophie" :

Andrea Saladino

2 publications dans cette catégorie

Publications dans "Atrophie" :

Francesco Bandello

2 publications dans cette catégorie

Publications dans "Atrophie" :

Sources (10000 au total)

Cultural Differences in Patients' Preferences for Paternalism: Comparing Mexican and American Patients' Preferences for and Experiences with Physician Paternalism and Patient Autonomy.

26 08 2022
DOI: 10.3390/ijerph191710663 PMID: 36078378

Following up on previous research demonstrating the high level of care realized by a paternalistic Mexican physician, the present research further explored the hypothesis that there are cultural diffe...

Decision Making Humans Paternalism Patient Preference Personal Autonomy +2 autres

A stated preference survey to explore patient preferences for novel preventive migraine treatments.

10 2022
DOI: 10.1111/head.14386 PMID: 36047857

The objective of this study was to explore patient preference for attributes of calcitonin gene-related peptide (CGRP) inhibitors for the preventive treatment of migraine and to describe differences i... CGRP inhibitors are a novel class of migraine drugs specifically developed for the preventive treatment of migraine. Clinicians should understand patient preferences for CGRP inhibitors to inform and ... Patients with migraine in the US and Germany were recruited to participate in an online discrete choice experiment (DCE) survey, which presented hypothetical treatment choices using five attributes: m... Of 680 who consented to participate, 506 participants completed the survey and were included in the study (US = 257; Germany = 249). Overall, participants placed highest importance (preference weight,... In this DCE assessing CGRP inhibitors attributes, the main driver of patient choice was treatment effectiveness, specifically reduced migraine severity, and consistent treatment effectiveness. Further...

Humans Patient Preference Calcitonin Gene-Related Peptide Migraine Disorders Germany +1 autres

Patient-Preference Diagnostics: Adapting Stated-Preference Methods to Inform Effective Shared Decision Making.

02 2023
DOI: 10.1177/0272989X221115058 PMID: 35904149

While clinical practice guidelines underscore the need to incorporate patient preferences in clinical decision making, incorporating meaningful assessment of patient preferences in clinical encounters... We propose an approach to efficiently diagnose preferences of patients for outcomes of treatment alternatives by leveraging prior information on patient preferences to generate adaptive choice questio... We identified 4 classes representing distinct preference profiles for patients who participated in a previous first-time anterior shoulder dislocation (FTASD) survey. Posterior probabilities of class ... Our results suggest that this approach could help diagnose patient preferences for treatments for a condition such as FTASD with acceptable precision using as few as 2 choice questions. Such preferenc... Approaches that combine patient preferences and clinical evidence can facilitate effective patient-provider communication and more patient-centric healthcare decisions. However, diagnosing individual-...

Humans Decision Making, Shared Patient Preference Shoulder Dislocation Surveys and Questionnaires +3 autres

Patient Preferences for Lung Cancer Interception Therapy.

01 Nov 2023
DOI: 10.1001/jamanetworkopen.2023.42681 PMID: 37948077

Interception therapy requires individuals to undergo treatment to prevent a future medical event, but little is known about preferences of individuals at high risk for lung cancer and whether they wou... To explore preferences of individuals at high risk for lung cancer for potential interception therapies to reduce this risk.... This survey study used a discrete-choice experiment and included hypothetical lung cancer interception treatments with 4 attributes: reduction in lung cancer risk over 3 years, injection site reaction... Attribute-level preference weights were estimated, and conditional relative attribute importance, maximum acceptable risks, and minimum acceptable benefits were calculated. Characteristics of responde... Of the 803 survey respondents, 495 (61.6%) were female, 138 (17.2%) were African American or Black, 55 (6.8%) were Alaska Native, American Indian, or Native American, 44 (5.5%) were Asian or Native Ha... In this survey study of individuals at high risk of lung cancer, most respondents were willing to consider interception therapy. These results suggest the importance of benefit-risk assessments for fu...

Adult Humans Female Male Lung Neoplasms +4 autres

Adaptation of the WOMAC for Use in a Patient Preference Study.

Jul 2023
DOI: 10.1007/s43441-023-00510-8 PMID: 37061632

To adapt a patient-reported outcome (PRO) measure, the Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), into efficacy attributes for a discrete choice experiment (DCE) survey design... The adaptation comprised four steps: (1) selecting domains of interest; (2) determining presentation and framing of selected attributes; (3) determining attribute levels; and (4) developing choice tas... The WOMAC pain and function domains were selected for adaption to two efficacy attributes. Two versions of the discrete choice experiment (DCE) instrument were created to compare efficacy using (1) to... This study adds to the growing literature regarding adapting PRO measures for patient preference studies. Such adaptation is important for designing a preference study that can incorporate a clinical ...

Humans Female Middle Aged Male Patient Preference +4 autres

Patient Preferences for Waiting Time and Kidney Quality.

09 2022
DOI: 10.2215/CJN.01480222 PMID: 35985699

Approximately 20% of deceased donor kidneys are discarded each year in the United States. Some of these kidneys could benefit patients who are waitlisted. Understanding patient preferences regarding a... This study uses a discrete choice experiment that presents a deceased donor kidney to patients who are waiting for, or have received, a kidney transplant. The choices involve trade-offs between accept... In total, 605 participants completed the discrete choice experiment. Respondents made trade-offs between kidney quality and waiting time. The average respondent would accept a kidney today, with 6.5 y... Participants preferred accepting a lower-quality kidney in return for shorter waiting time, particularly those who were older and had lower functional status....

Humans United States Middle Aged Kidney Failure, Chronic Patient Preference +4 autres

Preference of acromegaly patients for treatment attributes in Spain.

11 2023
DOI: 10.1007/s12020-023-03462-z PMID: 37507554

Acromegaly is a rare disease caused by increased growth hormone secretion and a subsequent increase in insulin-like growth factor I (IGF-I) levels. Patients display multiple comorbidities that affect ... A cross-sectional study based on interviews and a discrete choice experiment (DCE) in a Spanish cohort.... Adult patients diagnosed with acromegaly ≥1 year before the start of the study and under treatment were included. Treatment attributes were collected from patient testimony during face-to-face intervi... Sixty-seven patients completed the study. QoL improvement was the most important treatment attribute (37%), followed by IGF-I control (20%), blood sugar control (17%) and tumour control (13%). Seconda... QoL greatly influences patient treatment preference. Since acromegaly patients are informed and aware of their disease, treatment choices should always be shared with patients....

Adult Humans Quality of Life Insulin-Like Growth Factor I Acromegaly +3 autres

How culture influences patient preferences for patient-centered care with their doctors.

07 2023
DOI: 10.1080/17538068.2022.2095098 PMID: 37401877

Patient-centered care (PCC) is the prevailing model of care globally. However, most research on PCC has been conducted in Westernized countries or has focused on only two facets of PCC: decision-makin... Participants (... Participants from all four countries had similar preferences for empathy and shared decision-making. For other facets of PCC, participants in the Philippines and Australia expressed somewhat similar p... Empathy, information exchange, and shared decision-making are values shared across countries, while preferences for how the information is shared, and the importance of the doctor-patient relationship...

Humans Patient Preference Physician-Patient Relations Decision Making Australia +1 autres

Understanding treatment preferences and cognitive outcomes in patients with gliomas.

18 Sep 2024
DOI: 10.1007/s00520-024-08876-7 PMID: 39292365

Understanding how glioma patients value cognitive outcomes is essential to personalizing their treatment plans. The purpose of this study was to identify the modifiable cognitive functions most affect... Patients with gliomas were prospectively enrolled in focus groups and individual interviews using a standardized guide focusing on cognitive functions until saturation was achieved. Patient values and... Twenty participants participated, of whom 60% were female. Racial identification consisted of 75% White, 15% Black/African American, and 10% Other Racial Identification. The cognitive functions most e... Glioma patients in this study prioritized cognitive functions according to memory, personal identity, and their ability to communicate with loved ones independently of experiencing deficits in these f...

Humans Glioma Female Male Quality of Life +8 autres